Lilly is collaborating with an independent third-party to establish a continuous Data Attestation Service (DAS) wherein an independent copy of Lilly's clinical trial source data from Atom5™ will be electronically stored, for the purpose of attesting to users the completeness and accuracy of the data.
The Data Attestation Service ensures that regular checks are performed against the original source data (Atom5™) and the independent copy of the data stored at third-party environment.
To access reports from the Data Attestation Service or request an OnDemand Data Attestation, login with your DAS registered email ID.